From Bench to Bedside: New Technologies for Cancer Diagnosis and Treatment.

Schweiger, Michal-Ruth; Lehrach, Hans

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

From Bench to Bedside: New Technologies for Cancer Diagnosis and Treatment.

MPS-Authors

/persons/resource/persons50543

Schweiger, Michal-Ruth
Cancer Genomics (Michal-Ruth Schweiger), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

/persons/resource/persons50409

Lehrach, Hans
Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schweiger, M.-R., & Lehrach, H. (2008). From Bench to Bedside: New Technologies for Cancer Diagnosis and Treatment. Journal of International Biotechnology Law, 5(2), 82-84.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-7FE5-0

Abstract

According to the centre for disease control (CDC) malignant neoplasms are the second most common cause of death in the US in 2004 (1). One of the major problems is that most of the cancers are diagnosed in an advanced stage, which prohibits curative treatment. In order to circumvent these problems, we need to develop strategies that allow identification of risk patients and tumors at an early stage. In addition, it is necessary to identify prognostic and predictive biomarkers that guide patient treatment at different stages of the disease.